Skip to main content
Fig. 3 | BMC Pulmonary Medicine

Fig. 3

From: Initiating antiretroviral therapy within 2 weeks of anti-Pneumocystis treatment does not increase mortality or AIDS-defining events in patients with HIV-associated moderate to severe Pneumocystis pneumonia: results of a prospective observational multicenter study

Fig. 3

Kaplan–Meier curves depicting overall survival among all 363 participants in the two study arms (A), 351 participants with CD4+ T-cell counts less than 200 cells/μL (B), and 333 participants with CD4+ T-cell counts less than 100 cells/μL (C)

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us